Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T05:44:37.424Z Has data issue: false hasContentIssue false
  • English
  • Français

Paediatric psychotropic prescribing practices in Ireland

Published online by Cambridge University Press:  28 January 2014

F. McNicholas ,
N. Orakwue-Ononye  and
S. O’Hanrahan
F. McNicholas*
Affiliation:
Lucena Clinic, Rathgar, Dublin, Ireland Our Lady’s Children’s Hospital, Crumlin, University College Dublin, Ireland
N. Orakwue-Ononye
Affiliation:
Foothills Medical Center NW, Calgary, Canada
S. O’Hanrahan
Affiliation:
Lucena Clinic, Rathgar, Dublin, Ireland
*
*Address for correspondence: F. McNicholas, Consultant Child Psychiatrist and Professor of Child Psychiatry, Lucena Clinic, Rathgar, Dublin 6, Ireland. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

This study describes the attitudes, knowledge and prescribing of psychotropic medication in children.

Method

A study-specific questionnaire was mailed to all child psychiatrists, paediatricians and a group of registered general practitioners (GPs) from a selected Child and Adolescent Mental Health Services catchment area.

Results

In the 116 respondents who replied (39% response rate), psychotropic medication was generally valued and used by all groups (70.1%). Respondents believed that the majority (61.9%) of their non-medical colleagues would also value/support the use of medication and this endorsement influenced the respondents’ prescribing rates. Initiating medication was viewed as the province of child psychiatry (78.6%). Medication is felt to be justified in a wide variety of mental health disorders, their use being reserved for severe presentations, with psychostimulants and selective serotonin reuptake inhibitors being most used. A significant number of GPs (60.9%) and paediatricians (63.4%) were felt to be lacking in competence in psychotropic prescribing, with a general request for more seminars in this area (61.5%) with almost half (45%) of them believing that they would prescribe more often.

Conclusion

The use of psychotropic medication in children remains a valued and common practice in Ireland. Attitudinal and practice differences across professional groups exist, and although the experience is one of relative safety there was a strong desire for further education leading to a perceived increase in utilisation. The impact of perceived public opinion regarding psychotropic prescribing along with a lack of competence may represent a major barrier to effective prescribing, thus highlighting the importance of ongoing professional development and increased public health initiatives to increase knowledge and understanding in this increasingly important area.

Keywords

childrenpsychotropic medicationprescribing practices
Type
Original Research
Information
Irish Journal of Psychological Medicine , Volume 31 , Issue 1 , March 2014 , pp. 7 - 20
Copyright
© College of Psychiatrists of Ireland 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

America’s State of Mind (2011). A report by Medco Health Solutions, Inc. www.toxicpsychiatry.com/Google Scholar
Bennett, K, Teeling, M, Feely, J (2005). Overprescribing antidepressants to children: pharmacoepidemiological study in primary care. British Medical Journal 331, 1451–1452.Google Scholar
Bramble, D (1997). Psychostimulants and British child psychiatrists. Child Psychology and Psychiatry Review 2, 159–162.Google Scholar
Charles, J, Harrison, CM, Britt, H (2011). Management of children’s psychological problems in general practice 1970–1971, 1990–1991 and 2008–2009. Australian and New Zealand Journal of Psychiatry 45, 976–984.Google Scholar
College of Psychiatry in Ireland (2012). A consensus statement on the use of Benzodiazepines in specialist mental health services. http://www.irishpsychiatry.ie/Libraries/External_Events_Documents/CPsychI_position_paper_on_benzodiazepimes_June_2012.sflb.ashx. Accessed 19 February 2013.Google Scholar
Cooper, WO, Arbogast, PG, Ding, H, Hickson, GB, Fuchs, C, Ray, WA (2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics 6, 79–83.Google Scholar
Department of Health and Children (2006). A Vision for Change: Report of the Expert Group on Mental Health Policy. Government Publications Office: Dublin, Ireland.Google Scholar
Doherty, D, Moran, R, Kartalova-O’Doherty, Y, Walsh, D. HRB (2007). National Psychological Wellbeing and Distress Survey: Baseline Results. Health Research Board: Dublin, Ireland.Google Scholar
Drennan, J, Naughton, C, Allen, D, Hyde, A, O’Boyle, K, Felle, P, Treacy, MP, Butler, M (2011). Patients’ level of satisfaction and self-reports of intention to comply following consultation with nurses and midwives with prescriptive authority: a cross-sectional survey. International Journal Of Nursing Studies 48, 808–817.Google Scholar
Edwards, C, Howlett, E (2013). Putting knowledge to trial: ‘ADHD parents’ and the evaluation of alternative therapeutic regimes. Social Science & Medicine 81, 34–41.Google Scholar
Gallagher, S, Doherty, S, Tedstone, D (2010). A comparative analysis of users and non-users of prescribed psychotropic medication among individuals who reported mental health problems. The Internet Journal of Mental Health 6, 1–22.Google Scholar
Irish Medicines Board (2003). Notice Information; Human Medicines – Warning. Selective Serotonin Reuptake Inhibitors (SSRIs) Usage in Children. Irish Medicines Board. http://Quality/Advisory-Warning--Recall-Notices/Human-Medicines/Selective-Serotonin-Reuptake-Inhibitors-SSRIs.aspx. Accessed 12 February 2013.Google Scholar
Lockwood, E, Fealy, G (2008). Nurse prescribing as an aspect of future role expansion: the views of Irish clinical nurse specialists. Journal of Nursing Management 16, 813–820.Google Scholar
Mackintosh, V, Goin-Kochel, R, Myers, B (2012). “What Do You Like/Dislike About the Treatments You’re Currently Using?”: a qualitative study of parents of children with autism pectrum disorders. Focus On Autism & Other Developmental Disabilities 27, 51–60.Google Scholar
McNicholas, F (2001 a). Psychotropic prescribing practices of paediatricians in the UK. Child: Care, Health and Development 27, 497–508.Google Scholar
McNicholas, F (2001 b). Prescribing practices of child psychiatrists in the UK. Child Psychology & Psychiatry Review 6, 166–171.Google Scholar
Medicines and Health Care Products Review Agency (2004). Questions and Answers; Advice on SSRIs in Children from the Committee on Safety of Medicines. Medicines and Health Care Products Review Agency. http://www.mhra.gov.uk/home/groups/pl.../drugsafetymessage/con019472.pdf. Accessed 12 February 2013.Google Scholar
Merikangas, KR, Jian-ping, H, Rapoport, J, Vitiello, B, Olfson, M (2013). Medication use in US youth with mental disorders. JAMA Pediatrics 167, 141–148.Google Scholar
National Advisory Committee on Drugs (NACD) & Drug and Alcohol Information and Research Unit (DAIRU) (2007). Drug Use in Ireland and Northern Ireland: 2002/2003 Drug Prevalence Survey: Sedatives, Tranquillisers or Anti-Depressants Results: Bulletin 6. NACD and DAIRU: Dublin, Ireland.Google Scholar
National Institute for Health and Clinical Excellence (NICE) (2005). Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. NICE. http://publications.nice.org.uk/depression-in-children-and-young-people-cg28Google Scholar
O’Keeffe, N, McNicholas, F (2011). Paediatricians’ views on their role in the assessment and management of ADHD and autism. Irish Medical Journal 104, 282–284.Google Scholar
Olfson, M, Marcus, SC, Weissman, MM, Jenson, P (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 41, 514–521.Google Scholar
Rani, F, Murray, ML, Byrne, PJ, Wong, IC (2008). Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121, 1002–1009.Google Scholar
Rowe, L, Tonge, M, Melvin, G (2004). When should GPs prescribe SSRIs for adolescent depression. Australian Family Physician 33, 1005–1008.Google Scholar
Smith, B (2012). Inappropriate prescribing. Monitor on Psychology 43, 36.Google Scholar
Sparks, JA, Duncan, BL (2004). The ethics and science of medicating children. Ethical Human Psychology and Psychiatry 6, 25–39.Google Scholar
Timini, S (2010). The McDonaldization of childhood: children’s mental health in neo-liberal market cultures. Transcultural Psychiatry 47, 686–706.Google Scholar
Trott, GE, Badura, F, Wirth, S, Friese, HJ, Hollman-Wehren, B, Warnke, A (1995). Selbsteinschtzung des verordnungsverhaltens bei psychopharmaka an indern und jugendlicken. Ergebnisse einer Befragung von needergleassenen Arzten. Psychiatric Praxis 22, 235–239.Google Scholar
US Food and Drug Administration (2004). FDA issues public health advisory entitled: reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD). US Food and Drug Administration Department of Health and Human Services: Rockville, MD. http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm. Accessed 22 March 2004.Google Scholar
Zuvekas, S, Vitiello, B, Norquist, G (2006). Recent trends in stimulant medication use among U.S. children. American Journal of Psychiatry 163, 579–585.Google Scholar